ArticleAnimals : an open access journal from MDPI2026
Effects of Dietary
Article in Animals : an open access journal from MDPI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
background
methodsThirty finishing pigs were assigned to a control diet or a diet containing 3% PAR. Growth traits, serum oxidative and inflammatory indicators, and ovarian histomorphology were assessed in vivo. Multi-omics profiling was integrated with quantitative real-time PCR, Western blotting, and immunofluorescence assays. The properties of selected peptides and their potential interactions with candidate proteins were assessed separately using in silico prediction, molecular docking, and molecular dynamics simulations.
resultsPAR supplementation increased average daily gain and the ovary-to-body weight ratio and decreased serum malondialdehyde levels and follicular atresia, without significantly affecting feed intake, feed conversion ratio, or inflammatory cytokines. Multi-omics profiling associated PAR supplementation with changes in ovarian metabolism, antioxidant defense, immune regulation, and phosphorylation-related signaling. MGST2 and PPM1K were identified as candidate proteins, and their expression patterns were supported experimentally. Serum peptidomics identified GVSEIQQ as having higher abundance in the PAR group than in the control group, whereas GVEEHETL and PGIPT were detected only in the PAR group. In silico analyses predicted that these peptides were non-toxic, non-allergenic, and potentially antioxidant; these predictions require experimental validation. Molecular docking and molecular dynamics simulations suggested potential interactions of GVSEIQQ with MGST2 and GVEEHETL with PPM1K. However, these computational findings do not establish direct peptide-protein binding or functional effects in vivo.
conclusionsPAR shows potential as an alternative feed ingredient that may partially replace soybean meal while supporting growth and ovarian condition in finishing pigs. Further biochemical and in vivo studies are required to confirm the biological functions and mechanisms of the identified peptides.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.